Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Bitdeer Completes $330 Million Convertible Bond Issuance to Fund SEALMINER Miner Development and Data Center Expansion

Bitdeer Completes $330 Million Convertible Bond Issuance to Fund SEALMINER Miner Development and Data Center Expansion

ForesightNewsForesightNews2025/06/18 21:12
Show original

Foresight News reports that Bitdeer has completed a $330 million convertible bond issuance with a coupon rate of 4.875%, maturing in 2031. This marks Bitdeer’s third convertible bond financing in the past year, with proceeds earmarked for SEALMINER mining machine R&D and data center expansion. The private placement was offered to qualified institutional investors, exceeding the original $300 million target and including a $45 million overallotment option. According to Wednesday’s announcement, $129.6 million of the raised funds will be used for zero-strike call option hedging, and $36.1 million in cash will be used to replace previously issued 8.5% high-yield convertible bonds. As part of the debt restructuring, Bitdeer has repurchased $75.7 million of convertible bonds issued in August 2024 (which had set a record for the highest interest rate among listed mining companies), completing the swap through a combination of cash payment and the issuance of 8.1 million shares at an implied price of about $5 per share—representing a 57% discount to the current market price of $11.80. This arrangement allowed bondholders to exit profitably while significantly reducing the company’s interest burden. As a result, Bitdeer’s share price opened down 13% on Wednesday.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials

Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.

智通财经•2026/10/10 06:21